Anavex Life Sciences Corp (AVXL)

[McMagyar]

Great Read Thank You!
2 points: SLide #4 creates multiple new IND with multiple showing Pre-Clinical Validation: Depression, Anxiety, MS, Rett Syndrome, Alzheimers,
epilepsy, / Parkinsons and Schizophrenia are listed but have not yet reached Pre-Clinical Validation.
My second point is the Interim 12 WEEK data showed over 30% of ALL Participants had an OFF the CHART ADCS-ADL reaction of +3.21 ! That was only iwth 11 of 14 Patients reporting..
Any Delay is more likely due to the Revolutionary Success of A2-73 than it's failure, as 80% of the Tested Population showed response as yet unseen!